Sindell v. Abbott Laboratories Case Brief

California Supreme Court • 1980 • Docket #218200
607 P.2d 924 26 Cal. 3d 588 163 Cal. Rptr. 132 2 A.L.R. 4th 1061 1980 Cal. LEXIS 151 Torts Products Liability Civil Procedure

Complete case briefs with LSD+

Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.

Adaptive Case Views

Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.

Exam-Ready IRAC Format

We deliver the precise structure professors look for in exam answers.

Complex Cases, Clarified

We break down dense legal reasoning into something digestible, helping you grasp core concepts.

Case Brief Summary & Legal Analysis

4 min read

tl;dr: A woman injured by a generic drug (DES) taken by her mother could not identify the specific manufacturer. The court created “market-share liability,” allowing her to sue multiple manufacturers and hold them liable in proportion to their market share.

Legal Significance: This case established the groundbreaking “market-share liability” doctrine, a major exception to the traditional tort requirement that a plaintiff must prove causation by a specific defendant, particularly for fungible, harmful products where identification is impossible.

Case Facts & Court Holding

Key Facts & Case Background

Plaintiff Judith Sindell developed cancer allegedly caused by her mother’s ingestion of diethylstilbestrol (DES) during pregnancy. DES, a synthetic estrogen, was marketed between 1941 and 1971 by approximately 200 pharmaceutical companies to prevent miscarriages. The drug was fungible, produced from a common and mutually agreed-upon chemical formula, making various brands interchangeable. Due to the long latency period of her injuries and the generic nature of the drug, Sindell was unable to identify which specific company manufactured the DES her mother consumed. She brought a class action lawsuit against several major DES manufacturers, asserting theories of negligence, strict liability, and concerted action. The defendants demurred, arguing that the plaintiff’s inability to identify the specific tortfeasor who manufactured the injury-causing dose was fatal to her claim, as it failed to establish the essential element of causation. The trial court sustained the demurrers and dismissed the action.

Court Holding & Legal Precedent

Issue: Can a plaintiff, who was injured by a defective fungible product but cannot identify the specific manufacturer, recover against a group of manufacturers who produced a substantial share of that product on the market?

Yes. The court reversed the dismissal, establishing the doctrine of market-share liability. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial

IRAC Legal Analysis

Premium Feature Unlock

About IRAC analysis

IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.

Legal Issue

Can a plaintiff, who was injured by a defective fungible product but cannot identify the specific manufacturer, recover against a group of manufacturers who produced a substantial share of that product on the market?

Conclusion

Sindell created the novel and influential market-share liability doctrine, providing a remedy Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis

Legal Rule

Where a plaintiff is injured by a fungible product made by multiple Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ip

Legal Analysis

The court acknowledged the fundamental tort principle requiring a plaintiff to prove Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur

Flash-to-Full Case Opinions

Flash Summary

  • Plaintiff, injured by a generic drug (DES) taken by her mother,
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial